Advertisement
ATRC vs SIBN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and SIBN is a StrongBuy.
Momentum Indicator for ATRC turns negative, indicating new downward trend
ATRC saw its Momentum Indicator move below the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 71 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for ATRC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 24 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.
The Moving Average Convergence Divergence Histogram (MACD) for ATRC turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 37 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
ATRC moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
ATRC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +9.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in 212 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 182 of 244 cases where ATRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.766) is normal, around the industry mean (4.964). ATRC's P/E Ratio (266.091) is considerably higher than the industry average of (40.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.869) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
SIBN in +23.39% Uptrend, rising for three consecutive days on November 04, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SIBN advanced for three days, in 209 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on SIBN as a result. In 61 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 138 of 194 cases where SIBN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
Bearish Trend Analysis
The 10-day RSI Indicator for SIBN moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 20 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SIBN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
SIBN broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.958) is normal, around the industry mean (4.142). P/E Ratio (-73.455) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.801) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. SIBN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ATRC | SIBN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 81 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 92 | |
SMR RATING 1..100 | 88 | 93 | |
PRICE GROWTH RATING 1..100 | 36 | 36 | |
P/E GROWTH RATING 1..100 | 7 | 87 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SIBN's Valuation (8) in the Medical Specialties industry is significantly better than the same rating for ATRC (92). This means that SIBN’s stock grew significantly faster than ATRC’s over the last 12 months.
SIBN's Profit vs Risk Rating (92) in the Medical Specialties industry is in the same range as ATRC (100). This means that SIBN’s stock grew similarly to ATRC’s over the last 12 months.
ATRC's SMR Rating (88) in the Medical Specialties industry is in the same range as SIBN (93). This means that ATRC’s stock grew similarly to SIBN’s over the last 12 months.
ATRC's Price Growth Rating (36) in the Medical Specialties industry is in the same range as SIBN (36). This means that ATRC’s stock grew similarly to SIBN’s over the last 12 months.
ATRC's P/E Growth Rating (7) in the Medical Specialties industry is significantly better than the same rating for SIBN (87). This means that ATRC’s stock grew significantly faster than SIBN’s over the last 12 months.
| ATRC | SIBN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 74% |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 70% |
| Momentum ODDS (%) | 2 days ago 89% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 79% | N/A |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 79% |
| Advances ODDS (%) | 11 days ago 70% | 11 days ago 76% |
| Declines ODDS (%) | 5 days ago 82% | 2 days ago 74% |
| BollingerBands ODDS (%) | 2 days ago 71% | 2 days ago 78% |
| Aroon ODDS (%) | 2 days ago 75% | 2 days ago 71% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATRC’s FA Score shows that 1 FA rating(s) are green while SIBN’s FA Score has 1 green FA rating(s).
- ATRC’s FA Score: 1 green, 4 red.
- SIBN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATRC’s TA Score shows that 3 TA indicator(s) are bullish while SIBN’s TA Score has 3 bullish TA indicator(s).
- ATRC’s TA Score: 3 bullish, 6 bearish.
- SIBN’s TA Score: 3 bullish, 4 bearish.
Price Growth
ATRC (@Pharmaceuticals: Other) experienced а -2.90% price change this week, while SIBN (@Medical/Nursing Services) price change was -3.30% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.79%. For the same industry, the average monthly price growth was +4.31%, and the average quarterly price growth was +18.71%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was -4.49%, and the average quarterly price growth was -5.80%.
Reported Earning Dates
ATRC is expected to report earnings on Feb 23, 2027.
SIBN is expected to report earnings on Mar 01, 2027.
Industries' Descriptions
@Pharmaceuticals: Other (+1.79% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+1.37% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ATRC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then CERS could also see price increases.
| Ticker / NAME | Correlation To ATRC | 1D Price Change % | ||
|---|---|---|---|---|
| ATRC | 100% | +1.54% | ||
| CERS - ATRC | 42% Loosely correlated | +2.32% | ||
| SIBN - ATRC | 41% Loosely correlated | -2.90% | ||
| IRMD - ATRC | 38% Loosely correlated | +0.38% | ||
| ICUI - ATRC | 38% Loosely correlated | +1.11% | ||
| TMCI - ATRC | 37% Loosely correlated | -1.31% | ||
More | ||||